A phase II trial of gefitinib in patients with rising PSA following radical prostatectomy or radiotherapy

By Joensuu Greetta   Joensuu Timo   Nupponen Nina   Ruutu Mirja   Collan Juhani   Pesonen Sari   Hemminki Akseli  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 130-133

Informa Healthcare

Access to resources Recommend Favorite

The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA

By Grossklaus D.J.   Smith J.A.   Shappell S.B.   Coffey C.S.   Chang S.S.   Cookson M.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 5, 2002-09 ,pp. : 195-198

Elsevier

Access to resources Recommend Favorite

Continuous prostate-specific antigen rise despite salvage radiotherapy following radical prostatectomy: Pattern of clinical relapse and predictive factors

By          

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1138-1142

Spandidos Publications

Access to resources Recommend Favorite

Value of PSA (Prostate-specific Antigen) in the Detection of Prostate Cancer in Patients with Urological Symptoms. Results of a Multicentre Study

By Cooperative Group for the Diagnosis of Prostate Cancer   Filella X.   Molina R.   Ballesta A.M.   Gil M.J.   Allepuz C.   Rioja L.A.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1125-1128

Elsevier

Access to resources Recommend Favorite

Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the department of defense (DOD) Center for Prostate Disease Research (CPDR) national database

By Moul J.W.   Sun L.   Wu H.   McLeod D.G.   Amling C.   Lance R.   Foley J.   Sexton W.   Kusuda L.   Chung A.   Soderdahl D.   Donahue T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 447-455

Elsevier

Access to resources Recommend Favorite